This inventor holds 1 USPTO granted patent. Top assignee: Toray Industries, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Hiroshi Ohkuma: Innovator in Retinal Therapeutics
Introduction
Hiroshi Ohkuma is a notable inventor based in Nara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for ocular diseases. His work focuses on enhancing the growth of retinal pigment epithelial cells, which are crucial for maintaining vision.
Latest Patents
Hiroshi Ohkuma holds 1 patent related to a pharmaceutical composition designed for use as a retinal pigment epithelial cell growth stimulating agent. This innovative composition comprises an interferon and a pharmaceutically acceptable carrier. It is particularly useful as a therapeutic agent for various oculopathies, including pigmentary retinal degeneration, central chorioretinopathy, and macular dystrophy.
Career Highlights
Ohkuma is currently employed at Toray Industries, Inc., where he continues to advance his research in the pharmaceutical sector. His work has the potential to significantly impact the treatment of retinal diseases, improving the quality of life for many patients.
Collaborations
Some of his notable coworkers include Takao Tobe and Kanji Takahashi, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Hiroshi Ohkuma's innovative work in retinal therapeutics exemplifies the importance of research in addressing critical health issues. His contributions are paving the way for new treatments that could benefit countless individuals suffering from ocular diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile